Is Guidance Alone Enough? Systematic Review Protocol on Physical Activity Counseling in Hypertension
Keywords:
Hypertension, Physical Activity, CounselingAbstract
Objective: To present a systematic review protocol aimed at identifying and analyzing the impacts of physical-activity counseling in patients with hypertension. Methods: This protocol was developed in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020. The search strategy followed the PICOS framework and included only randomized clinical trials involving adults with hypertension. Study search and selection will be conducted independently by two reviewers in the PubMed, Embase, PsycInfo, CINAHL, and LILACS databases, with no restrictions on language or publication date. Risk of bias will be assessed using the Risk of Bias 2.0 (RoB 2.0) tool, and the certainty of evidence will be rated using the GRADE approach. Data from the included studies will be extracted into a form developed by the authors, and the findings will be presented in maps, charts, tables, or figures, aiming to answer the research question and meet the objectives of this study. If adequate methodological and statistical homogeneity is identified among the included studies, a meta-analysis will be performed.
References
Eakin EG, Reeves MM, Lawler SP, et al. The Logan Healthy Living Program: a cluster randomized trial of a telephone-delivered physical activity and dietary behavior intervention for primary care patients with type 2 diabetes or hypertension from a socially disadvantaged community--rationale, design and recruitment. Contemp Clin Trials. 2008;29(3):439-454. doi:10.1016/j.cct.2007.10.005
Appel LJ, Champagne CM, Harsha DW, et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA. 2003;289(16):2083-2093. doi:10.1001/jama.289.16.2083
Lee IM, Shiroma EJ, Lobelo F, et al. Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy. Lancet. 2012;380(9838):219-229. doi:10.1016/S0140-6736(12)61031-9
World health statistics 2023: monitoring health for the SDGs, Sustainable Development
Goals. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO.
Nilson EAF, Andrade R da CS, Brito DA de, Oliveira ML de. Custos atribuíveis a obesidade, hipertensão e diabetes no Sistema Único de Saúde, Brasil, 2018. Revista Panamericana de Salud Pública 2020.
Burke V, Beilin LJ, Cutt HE, Mansour J, Wilson A, Mori TA. Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial. J Hypertens. 2005;23(6):1241-1249. doi:10.1097/01.hjh.0000170388.61579.4f
Burke V, Mansour J, Mori TA, Beilin LJ, Cutt HE, Wilson A. Changes in cognitive measures associated with a lifestyle program for treated hypertensives: a randomized controlled trial (ADAPT). Health Educ Res. 2008;23(2):202-217. doi:10.1093/her/cym017
Dudum R, Juraschek SP, Appel LJ. Dose-dependent effects of lifestyle interventions on blood lipid levels: Results from the PREMIER trial. Patient Educ Couns. 2019;102(10):1882-1891. doi:10.1016/j.pec.2019.05.005
Ayodapo A, Olukokun T. Lifestyle counselling and behavioural change: role among adult hypertensives in a rural tertiary institution. S Afr Fam Pract. 2019;61(3):91–96. doi:10.1080/20786190.2019.1569453
Aghakhani N, Parizad N, Soltani B, Khademvatan K, Rahimi Z. The effect of the blended education program on treatment concordance of patients with hypertension: A single-blind randomized, controlled trial. J Vasc Nurs. 2019;37(4):250-256. doi:10.1016/j.jvn.2019.08.001
Dasgupta K, Rosenberg E, Joseph L, et al. Physician step prescription and monitoring to improve ARTERial health (SMARTER): A randomized controlled trial in patients with type 2 diabetes and hypertension. Diabetes Obes Metab. 2017;19(5):695-704. doi:10.1111/dom.12874
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al. A declaração PRISMA 2020: diretriz atualizada para relatar revisões sistemáticas. Rev Panam Salud Publica. 2022;46:e112. doi.org/10.26633/RPSP.2022.112
Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898. Published 2019 Aug 28. doi:10.1136/bmj.l4898
Murad MH, Asi N, Alsawas M, Alahdab F. New evidence pyramid. Evid Based Med. 2016;21(4):125-127. doi:10.1136/ebmed-2016-110401
Brasil. Ministério da Saúde. Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde. Departamento de Gestão e Incorporação de Tecnologias em Saúde. Diretrizes metodológicas : elaboração de revisão sistemática e meta-análise de ensaios clínicos randomizados [recurso eletrônico] / Ministério da Saúde, Secretaria de Ciência, Tecnologia, Inovação e Insumos Estratégicos em Saúde, Departamento de Gestão e Incorporação de Tecnologias em Saúde. – Brasília : Ministério da Saúde, 2021.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Revista de Divulgação Científica Sena Aires

This work is licensed under a Creative Commons Attribution 4.0 International License.
-
Atribuição — Você deve dar o crédito apropriado, prover um link para a licença e indicar se mudanças foram feitas. Você deve fazê-lo em qualquer circunstância razoável, mas de nenhuma maneira que sugira que o licenciante apoia você ou o seu uso.
- Sem restrições adicionais — Você não pode aplicar termos jurídicos ou medidas de caráter tecnológico que restrinjam legalmente outros de fazerem algo que a licença permita.
